CN101918430A - 非糖基化蛋白质的纯化 - Google Patents

非糖基化蛋白质的纯化 Download PDF

Info

Publication number
CN101918430A
CN101918430A CN2009801023313A CN200980102331A CN101918430A CN 101918430 A CN101918430 A CN 101918430A CN 2009801023313 A CN2009801023313 A CN 2009801023313A CN 200980102331 A CN200980102331 A CN 200980102331A CN 101918430 A CN101918430 A CN 101918430A
Authority
CN
China
Prior art keywords
chromatography
polypeptide
carried out
exchange chromatography
hydrophobic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009801023313A
Other languages
English (en)
Chinese (zh)
Inventor
R·法尔肯施泰因
B·魏丹兹
C·吉赛尔
S·格赖塔纳
A·格罗斯曼
F·赫西
B·克雷默
M·蓬皮阿蒂
A·肖布马尔
N·菲尔勒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Priority to CN201710044891.4A priority Critical patent/CN107033233A/zh
Publication of CN101918430A publication Critical patent/CN101918430A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CN2009801023313A 2008-01-18 2009-01-15 非糖基化蛋白质的纯化 Pending CN101918430A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710044891.4A CN107033233A (zh) 2008-01-18 2009-01-15 非糖基化蛋白质的纯化

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08000884.0 2008-01-18
EP08000884 2008-01-18
PCT/EP2009/000192 WO2009090056A2 (en) 2008-01-18 2009-01-15 Purification of not-glycosylated polypeptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201710044891.4A Division CN107033233A (zh) 2008-01-18 2009-01-15 非糖基化蛋白质的纯化

Publications (1)

Publication Number Publication Date
CN101918430A true CN101918430A (zh) 2010-12-15

Family

ID=39810157

Family Applications (2)

Application Number Title Priority Date Filing Date
CN2009801023313A Pending CN101918430A (zh) 2008-01-18 2009-01-15 非糖基化蛋白质的纯化
CN201710044891.4A Pending CN107033233A (zh) 2008-01-18 2009-01-15 非糖基化蛋白质的纯化

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201710044891.4A Pending CN107033233A (zh) 2008-01-18 2009-01-15 非糖基化蛋白质的纯化

Country Status (9)

Country Link
US (3) US20110034672A1 (cg-RX-API-DMAC7.html)
EP (1) EP2245044A2 (cg-RX-API-DMAC7.html)
JP (2) JP5944101B2 (cg-RX-API-DMAC7.html)
KR (1) KR20100103595A (cg-RX-API-DMAC7.html)
CN (2) CN101918430A (cg-RX-API-DMAC7.html)
AU (1) AU2009204998B2 (cg-RX-API-DMAC7.html)
CA (1) CA2711375C (cg-RX-API-DMAC7.html)
IL (1) IL206158A (cg-RX-API-DMAC7.html)
WO (1) WO2009090056A2 (cg-RX-API-DMAC7.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102219848A (zh) * 2011-05-25 2011-10-19 浙江海正药业股份有限公司 重组人干扰素β-1a的纯化方法
CN104710527B (zh) * 2015-02-28 2018-08-24 苏州金盟生物技术有限公司 一种生物制品的内毒素去除方法
CN114341634A (zh) * 2019-09-25 2022-04-12 豪夫迈·罗氏有限公司 利用预测的洗脱缓冲液盐浓度的阳离子色谱

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101918430A (zh) * 2008-01-18 2010-12-15 弗·哈夫曼-拉罗切有限公司 非糖基化蛋白质的纯化
DE102009032179A1 (de) * 2009-07-07 2011-01-13 Biogenerix Ag Verfahren zur Reinigung von Interferon beta
US20140154233A1 (en) 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
HUE049756T2 (hu) * 2015-11-09 2020-10-28 Biological E Ltd Ipari méretekben is alkalmazható eljárás biológiailag aktív, rekombináns hordozófehérjék kinyerésére
KR20220145361A (ko) * 2020-02-24 2022-10-28 노파르티스 아게 재조합적으로 생성된 폴리펩타이드의 정제
KR20230125179A (ko) * 2020-12-23 2023-08-29 재즈 파마슈티칼즈 아일랜드 리미티드 전하-차폐 융합 단백질의 정제 방법
CN113480632B (zh) * 2021-07-30 2023-02-03 宁波人健药业集团股份有限公司 一种在CHO细胞中表达的重组蛋白rhCG纯化工艺
TW202403043A (zh) * 2022-03-18 2024-01-16 美商健臻公司 重組人類酸性鞘磷脂酶醫藥組合物及方法
CN117024561B (zh) * 2023-10-10 2024-02-20 哈药集团生物工程有限公司 一种聚乙二醇修饰干扰素的纯化方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH651308A5 (de) * 1980-07-01 1985-09-13 Hoffmann La Roche Interferone und deren herstellung.
US5696238A (en) * 1991-08-20 1997-12-09 Chiron Corporation Purified GP120 composition retaining natural conformation
DE4329756A1 (de) * 1993-09-03 1995-03-09 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von alpha-Interferon
EP0626448A3 (de) * 1993-05-26 1998-01-14 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung und Reinigung von alpha-Interferon
EP1104809A1 (en) * 1994-04-09 2001-06-06 F. Hoffmann-La Roche Ag Process for producing alpha-interferon
TW517067B (en) * 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
KR100443890B1 (ko) 2001-04-11 2004-08-09 한미약품 주식회사 재조합 대장균으로부터 인간 성장 호르몬의 정제 방법
CN1233816C (zh) * 2002-04-16 2005-12-28 海南海梁生物高科技有限公司 酵母重组株及IFNα-la干扰素的纯化方法
SI1501369T1 (sl) * 2002-04-26 2015-10-30 Genentech, Inc. Neafinitetno čiščenje proteinov
SI1656455T1 (sl) * 2003-08-13 2012-12-31 Sandoz Ag Postopek za čiščenje rekombinantnih polipeptidov
ES2285543T3 (es) 2003-11-05 2007-11-16 Ares Trading S.A. Procedimiento para la purificacion de la proteina de union a il-18.
ATE446314T1 (de) 2003-12-22 2009-11-15 Ares Trading Sa Methode zur reinigung von fsh
SE0400886D0 (sv) * 2004-04-02 2004-04-02 Amersham Biosciences Ab Process of purification
WO2005113592A2 (en) * 2004-05-19 2005-12-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
CA2602947A1 (en) 2005-03-24 2006-09-28 Straumann Holding Ag Method for protein purification comprising heat incubation in acetic acidic solution
WO2007016250A1 (en) 2005-07-28 2007-02-08 Genvec, Inc. Method of purifying protein
CN1916024A (zh) * 2005-08-17 2007-02-21 海南国栋药物研究所有限公司 高比活人α-2b干扰素突变体序列、酵母表达质粒的构建及菌株筛选和纯化方法
JP5364375B2 (ja) * 2005-10-04 2013-12-11 ザイモジェネティクス リミテッド ライアビリティ カンパニー Il−29の生産および精製の方法
EP1963367A4 (en) 2005-12-06 2009-05-13 Amgen Inc POLISHING STEPS IN MULTI-STAGE PROTEIN PURIFICATION TREATMENTS
CN101918430A (zh) * 2008-01-18 2010-12-15 弗·哈夫曼-拉罗切有限公司 非糖基化蛋白质的纯化
CN103864915B (zh) * 2012-12-07 2016-06-08 天津未名生物医药有限公司 纯化重组人干扰素α2b的方法和试剂盒
CN104356223B (zh) * 2014-11-26 2017-11-10 安徽安科生物工程(集团)股份有限公司 高纯度重组人干扰素α2b的制备方法

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102219848A (zh) * 2011-05-25 2011-10-19 浙江海正药业股份有限公司 重组人干扰素β-1a的纯化方法
CN102219848B (zh) * 2011-05-25 2014-01-22 浙江海正药业股份有限公司 重组人干扰素β-1a的纯化方法
CN104710527B (zh) * 2015-02-28 2018-08-24 苏州金盟生物技术有限公司 一种生物制品的内毒素去除方法
CN114341634A (zh) * 2019-09-25 2022-04-12 豪夫迈·罗氏有限公司 利用预测的洗脱缓冲液盐浓度的阳离子色谱
CN114341634B (zh) * 2019-09-25 2024-01-23 豪夫迈·罗氏有限公司 利用预测的洗脱缓冲液盐浓度的阳离子色谱
US12674784B2 (en) 2019-09-25 2026-07-07 Hoffmann-La Roche Inc. Cation chromatography using predicted elution buffer salt concentration

Also Published As

Publication number Publication date
KR20100103595A (ko) 2010-09-27
AU2009204998B2 (en) 2014-03-27
US9481706B2 (en) 2016-11-01
JP2011509963A (ja) 2011-03-31
CA2711375C (en) 2019-04-16
JP5944101B2 (ja) 2016-07-05
IL206158A0 (en) 2010-12-30
US20110034672A1 (en) 2011-02-10
US20130190478A1 (en) 2013-07-25
CA2711375A1 (en) 2009-07-23
WO2009090056A3 (en) 2010-01-21
CN107033233A (zh) 2017-08-11
WO2009090056A2 (en) 2009-07-23
AU2009204998A1 (en) 2009-07-23
US20140220633A1 (en) 2014-08-07
JP2014210797A (ja) 2014-11-13
EP2245044A2 (en) 2010-11-03
IL206158A (en) 2016-09-29

Similar Documents

Publication Publication Date Title
CA2711375C (en) Purification of not-glycosylated polypeptides
DK3040346T3 (en) PROCEDURE FOR CLEANING THE GRANULOCYT COLONY STIMULATING FACTOR, G-CSF
CN100384874C (zh) 用蛋白质a和离子交换层析来纯化抗体
TWI395619B (zh) 層析方法
CN102712673B (zh) 用于纯化含fc的蛋白的色谱方法
KR20070072510A (ko) 항체 정제를 위한 친화도- 및 이온 교환- 크로마토그래피
CN101889023A (zh) Peg化的多肽的纯化
US20220017570A1 (en) Method for purifying pegylated protein
KR20200104381A (ko) 페길화 단백질 조성물의 제공 방법
CN103703015B (zh) 阳离子和阴离子交换层析法
JP5635682B2 (ja) 疎水性相互作用クロマトグラフィー法
US20250215050A1 (en) Compositions and methods for purifying biological fluids
Akhtar et al. Evaluation of the efficiency of protein A affinity chromatography to purify a monoclonal antibody for cancer treatment and its purity analysis
KR20200104382A (ko) 페길화 단백질 조성물의 제공 방법
HK1193617A (en) Cation and anion exchange chromatography method
HK1181458A (en) Hydrophobic interaction chromatography method
HK40038492A (en) Process for providing pegylated protein composition
HK1193617B (en) Cation and anion exchange chromatography method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20101215